Revanta Pharmaceuticals Llp - Company Profile

It is a chemicals limited liability partnership based in Kanpur, Uttar Pradesh, India, established in 2020.
2020 Kanpur, Uttar Pradesh, India Active
Last Updated:
Access Report
About Revanta Pharmaceuticals Llp

Revanta Pharmaceuticals Llp, a active limited liability partnership, was established on 03 July 2020 in Kanpur, Uttar Pradesh, India. Engaging in manufacturing within the chemicals sector, it holds LLPIN: AAS-7624. Registered under ROC Roc Kanpur. It has total obligation of contribution of ₹0.10 M.

Its leadership includes Joycee Vijay Rastogi (Designated Partner), Varsha Rastogi (Designated Partner). Past directors included Abhishek Jain, Varsha Rastogi. Its latest date of accounts and solvency statement 31 March 2025. It is based at 117/132 A, P Block Hitkari Nagar, Kakadeo, Kanpur, Uttar Pradesh, 208025.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    AAS-7624

  • Incorporation Date

    03 July 2020

  • Total Obligation of Contribution

    ₹0.10 M

  • ROC Code

    Roc Kanpur

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 0.10 M
  • Company Age 5 Year, 9 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Revanta Pharmaceuticals Llp

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Revanta Pharmaceuticals Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Revanta Pharmaceuticals Llp?
Current Designated Partners
Name Designation Appointment Date Status
Joycee Vijay Rastogi Designated Partner 03 Jul 2020 Current
Varsha Rastogi Designated Partner 16 Feb 2023 Current
Past Designated Partners
Name Designation Cessation Status
Pramod Abcsdd Designated Partner - Past
Pramod Abcsdd Designated Partner 30 May 2023 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Revanta Pharmaceuticals Llp.

Enhance accessibility to Revanta Pharmaceuticals Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Revanta Pharmaceuticals Llp revenue growth over time
Revanta Pharmaceuticals Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Revanta Pharmaceuticals Llp?

Unlock access to Revanta Pharmaceuticals Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Revanta Pharmaceuticals Llp?

Unlock and access historical data on people associated with Revanta Pharmaceuticals Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Revanta Pharmaceuticals Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Revanta Pharmaceuticals Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Revanta Pharmaceuticals Llp
Recent Activity within the Organization
  • Annual General Meeting

    Revanta Pharmaceuticals Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records. was recorded as a recent event.

  • Statement of Assets & Liabilities

    Revanta Pharmaceuticals Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur. was recorded as a recent event.

  • Director Appointment

    Varsha Rastogi was appointed as a Designated Partner was appointed as a Designated Partner on 16 Feb 2023 & has been associated with this company since 3 years 1 month . was recorded as a recent event.

  • Director Appointment

    Joycee Vijay Rastogi was appointed as a Designated Partner was appointed as a Designated Partner on 03 Jul 2020 & has been associated with this company since 5 years 9 months . was recorded as a recent event.

  • LLP Incorporation

    The activity Revanta Pharmaceuticals Llp was registered on 03 Jul 2020 with Roc Kanpur & aged 5 years 9 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Revanta Pharmaceuticals Llp?

The LLPIN of Revanta Pharmaceuticals Llp is AAS-7624.

Where is Revanta Pharmaceuticals Llp headquartered?

Revanta Pharmaceuticals Llp is headquartered at 117/132 A, P Block Hitkari Nagar, Kakadeo, Kanpur, Uttar Pradesh, 208025.

When was Revanta Pharmaceuticals Llp incorporated?

Revanta Pharmaceuticals Llp was incorporated on 03 July 2020.

Who are the current directors of Revanta Pharmaceuticals Llp?

The current directors of Revanta Pharmaceuticals Llp are

What is the primary industry of Revanta Pharmaceuticals Llp?

The primary industry of Revanta Pharmaceuticals Llp is Chemicals.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available